A study of association of eosinophil count with severity and outcome in corona virus disease (COVID-19) in paediatric cases

ABSTRACT

Recently, COVID-19 has been investigated for questions pertaining to eosinophils. Eosinopenia, often known as a decrease in eosinophil levels, was identified as a characteristic feature associated with SARSCoV- 2 infection. However, in the past researchers have found conflicting evidence on the connection between eosinopenia and the severity of the disease. It is not quite obvious if these changes occurred as a consequence of the immunomodulation that the medication provided or of the disease process itself. In addition, additional study is required to shed light on the possible connection that exists between the eosinophil count and the development and severity of COVID-19. The current analysis was to report changes in the eosinophil count in symptomatic COVID- 19 patients and to link such changes with severity and prognosis. The purpose of the investigation was also to record variations in the eosinophil count.